REFERENCIAS BIBLIOGRÁFICAS “CÓMO USAR LOS ÁCIDOS GRASOS PARA EQUILIBRAR LOS PROCESOS INFLAMATORIOS Y CELULARES”
1. Wijendran V, Huang MC, and al. Efficacy of dietary 9. Maki KC, Bays HE and al. Effects of prescription
arachidonic acid provided as triglyceride or phos-
omega-3-acid ethyl esters, coadministered with
pholipid as substrates for brain arachidonic acid
atorvastatin, on circulating levels of lipoprotein
accretion in baboon neonates.Pediatr Res. 2002
particles, apolipoprotein CIII, and lipoprotein-
associated phospholipase A2 mass in men and
2. Maki KC, Reeves MS and al. Krill oil supplemen-
women with mixed dyslipidemia. J Clin Lipidol
tation increases plasma concentrations of ei-
cosapentaenoic and docosahexaenoic acids in 10. Maki KC, Dicklin MR and al. Baseline lipoprotein
overweight and obese men and women.Nutr Res.
lipids and low-density lipoprotein cholesterol
response to prescription omega-3 acid ethyl es-
3. Hamburg II study: A Single Centre, Open-Label,
ter added to Simvastatin therapy. Am J Cardiol
Randomized Two-Way Crossover Study to Assess
Changes in EPA and DHA in Phospholipid Mem- 11. Maki KC, Bays HE, Effects of prescription omega-
branes after Eight Weeks of Daily Intake of 2 g Su-
3-acid ethyl esters, coadministered with ator-
perbaTM Krill Oil or 2 g Omega-3 Enriched Fish Oil
vastatin, on circulating levels of lipoprotein
in Healthy Male and Female Subjects. NutraCos
particles, apolipoprotein CIII, and lipoprotein-as-
sociated phospholipase A2 mass in men and wo-
4. Kark JD, Goldberger N and al. Energy intake and
men with mixed dyslipidemia. J Clinical Lipidolo-
leukocyte telomere length in young adults. Am J
12. Mori TA, Burke VPurified eicosapentaenoic and
5. M. Nathaniel Mead.Molecular Biology: Telome-
docosahexaenoic acids have differential effects
rase Tells on Lifestyle. Environ Health Perspect
on serum lipids and lipoproteins, LDL particle
size, glucose, and insulin in mildly hyperlipidemic
6. Watson KE, Boström K and al. TGF-beta 1 and
25-hydroxycholesterol stimulate osteoblast-like 13. Maki KC, Dicklin MR and al. Baseline lipoprotein
vascular cells to calcify. JCI 1994;93:2106-13
lipids and low-density lipoprotein cholesterol
response to prescription omega-3 acid ethyl
7. Mody N, Parhami F and al . Oxidative stress modu-
ester added to Simvastatin therapy. Am J Card
lates osteoblastic differentiation of vascular and
bone cells. Free Radic Biol Med 2001;31:509-19
14. Kromann N. Epidemiological studies in the Uper-
8. Dhingra R, Sullivan LM and al. Relations of serum
navik district, Greenland. Incidence of some chro-
phosphorus and calcium levels to the incidence
nic diseases 1950-1974. Acta Med Scand 1980;
of cardiovascular disease in the community. Arch
15. Burr ML, Fehily AM and al. Effects of changes in 26. Kidd PM. Omega-3 DHA and EPA for cognition, be-
fat, fish, and fibre intakes on death and myocar-
havior, and mood: clinical findings and structural-
dial reinfarction: diet and reinfarction trial (DART).
functional synergies with cell membrane phos-
pholipids. Altern Med Rev. 2007 Sep;12(3):207-27.
16. Von Schacky C, Angerer P and al. The effect of die- 27. Albert CM, Campos H and al. Blood levels of long-
tary omega-3 fatty acids on coronary atheroscle-
chain n-3 fatty acids and the risk of sudden death.
rosis. A randomized, double-blind, placebo-con-
New Engl J Med, 2002 346(15):1113-18.
28. Harris WS, Von Schacky C. The Omega-3 Index: a
17. Rissanen T, Voutilainen S and al. Fish oil-derived
new risk factor for death from coronary heart di-
fatty acids, docosahexaenoic acid and doco-
sapentaenoic acid, and the risk of acute coronary 29. Siscovick DS, Raghunathan TE and al. Dietary in-
events: the Kuopio ischaemic heart disease risk
take and cell membrane levels of long-chain n-3
polyunsaturated fatty acids and the risk of pri-
18. Moertl D, Hammer A and al. Dose-dependent
mary cardiac arrest. JAMA 1995; 274: 1363-1367
effects of omega-3-polyunsaturated fatty acids 30. Bunea R, El Farrah K, Deutsch L.Evaluation of the
on systolic left ventricular function, endothelial
effects of Neptune Krill Oil on the clinical course
function, and markers of inflammation in chro-
of hyperlipidemia. Altern Med Rev 2004;9(4):420-
nic heart failure of nonischemic origin: a double-
blind, placebo-controlled, 3-arm study. Am Heart
31. Deutsch L. Evaluation of the effect of Neptune
Krill Oil on chronic inflammation and arthritic
19. Ueshima H, Stamler J and al. Food omega-3 fatty
symptoms.J Am Coll Nutr. 2007 Feb;26(1):39-48
acid intake of individuals (total, linolenic acid,
long-chain) and their blood pressure: INTERMAP 32. Fosshaug LE, Berge RK and al. Krill oil attenuates
left ventricular dilatation after myocardial infarc-
tion in rats. Lipids health Dis. 2011 Dec 29;10:245
20. Park Y, Oh SH and al. Association between 24-hour
ambulatory blood pressure and erythrocyte n-3 33. Ierna M, Kerr A and al. Supplementation of diet
polyunsaturated fatty acids in Korean subjects
with krill oil protects against experimental rheu-
matoid arthritis. BMC Musculoskelet Disord. 2010
21. Liu JC, Conklin SM and al. Long-chain omega-3
fatty acids and blood pressure. Am J Hyperten- 34. Grimstad T, Bjørndal B and al. Dietary supplemen-
tation of krill oil attenuates inflammation and oxi-
dative stress in experimental ulcerative colitis in
22. Sagara M, Njelekela M and al. Effects of docosa-
rats. Scand J Gastroenterol. 2012 Jan;47(1):49-58
hexaenoic Acid supplementation on blood pres-
sure, heart rate, and serum lipids in Scottish men 35. Sampalis F, Bunea R and al. Evaluation of the
with hypertension and hypercholesterolemia. Int
effects of Neptune Krill Oil on the management
of premenstrual syndrome and dysmenorrhea. Al-
23. Mori TA, Bao DQ and al. Docosahexaenoic acid
but not eicosapentaenoic acid lowers ambulatory 36. Harris WS. Expert opinion: omega-3 fatty acids
blood pressure and heart rate in humans. Hyper-
and bleeding-cause for concern?. Am J Cardiol.
24. Alexander JW. Immunonutrition: the role of ome-
ga-3 fatty acids. Nutrition 1998; 14: 627-33
25. Toft, I et al. Effects of n-3 polyunsaturated fatty
acids on glucose homeostasis and blood pressure
in essential hypertension. Ann Intern Med 1995;
A cluster of single nucleotide polymorphisms in the 5H-leader ofthe human dopamine D3 receptor gene (DRD3) and itsSinthuja Sivagnanasundarama,1, Alex G. Morrisa,1, Emma J. Gaitondeb, PeterJ. McKennac, John D. Mollonb, David M. Hunta,*aDepartment of Molecular Genetics, Institute of Ophthalmology, University College London, Bath Street, London, EC1V 9EL, UKbDepartment of Experimental Psycho
Questions for final writing exemination 1. After some days of nasal trauma in breathing complaints of increasing difficulty, continuous pain and fever developed. What is your first diagnosis: 2. A three-year old child is inattentive, has recurrent sinusitis and sleeps with open mouth, snoring. What is your diagnosis: 3. A 55-year old patient has a gradually developed nasal obstruction. Re